Clearpoint Neuro Inc (CLPT)

Jun 15, 2026

ClearPoint Neuro Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesShort-Term Outlook - newsline.com

Jun 15, 2026

Jun 09, 2026

Stifel reiterates Clearpoint Neuro stock rating on neurosurgery platform - Investing.com

Jun 09, 2026

Jun 09, 2026

Stifel reiterates Clearpoint Neuro stock rating on neurosurgery platform By Investing.com - Investing.com Canada

Jun 09, 2026

Jun 08, 2026

ClearPoint Neuro (CLPT) director exercises options and withholds shares for taxes - Stock Titan

Jun 08, 2026

Jun 07, 2026

Why (CLPT) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Jun 07, 2026

Jun 04, 2026

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - ACCESS Newswire

Jun 04, 2026

Jun 02, 2026

Director at ClearPoint Neuro (NASDAQ: CLPT) sells shares to cover taxes - Stock Titan

Jun 02, 2026

Jun 01, 2026

CLPT: Director compensation shares (5,145) to be sold via Form 144 (06/01/2026) - Stock Titan

Jun 01, 2026

May 29, 2026

[144] ClearPoint Neuro, Inc. SEC Filing - Stock Titan

May 29, 2026

May 29, 2026

ClearPoint Neuro, Inc.: ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - FinanzNachrichten.de

May 29, 2026

May 28, 2026

Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - Moomoo

May 28, 2026

May 28, 2026

Director Of ClearPoint Neuro Sold 25% Of Their Shares - simplywall.st

May 28, 2026

May 28, 2026

ClearPoint Neuro plans entry into focused ultrasound market By Investing.com - Investing.com India

May 28, 2026

May 27, 2026

ClearPoint Neuro plans entry into focused ultrasound market - Investing.com UK

May 27, 2026

May 27, 2026

Understanding Momentum Shifts in (CLPT) - Stock Traders Daily

May 27, 2026

May 27, 2026

Brain ultrasound deal tests drug delivery across blood-brain barrier - Stock Titan

May 27, 2026

May 26, 2026

How The ClearPoint Neuro (CLPT) Narrative Is Shifting On Partnerships Valuation And FDA Risks - Yahoo Finance

May 26, 2026

May 26, 2026

ClearPoint Neuro (CLPT) director receives grant of 12,820 RSUs - Stock Titan

May 26, 2026

May 26, 2026

ClearPoint Neuro (CLPT) director receives 12,820 restricted stock units in equity grant - Stock Titan

May 26, 2026

May 26, 2026

[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity - Stock Titan

May 26, 2026

May 26, 2026

Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units - Stock Titan

May 26, 2026

May 26, 2026

Director at ClearPoint Neuro (NASDAQ: CLPT) awarded 12,820 RSUs - Stock Titan

May 26, 2026

May 26, 2026

Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units grant - Stock Titan

May 26, 2026

May 25, 2026

CLPT Q1 2026 Earnings: EPS Misses Estimates as Revenue Details Remain UndisclosedAnnual Financial Report - newsline.com

May 25, 2026

May 22, 2026

ClearPoint Neuro Shareholders Approve Incentive Plan and Directors - The Globe and Mail

May 22, 2026

May 22, 2026

ClearPoint Neuro Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock MovementPre-Earnings Setup - newsline.com

May 22, 2026

May 21, 2026

Director Matthew Klein of ClearPoint Neuro (CLPT) receives 12,417 shares from RSU vesting - Stock Titan

May 21, 2026

May 21, 2026

Tax sale by ClearPoint (CLPT) director after RSU vesting - Stock Titan

May 21, 2026

May 21, 2026

Director at ClearPoint Neuro (NASDAQ: CLPT) gains 12,417 shares via RSU vesting - Stock Titan

May 21, 2026

May 21, 2026

ClearPoint Neuro (CLPT) investors approve directors, pay and updated incentive plan - Stock Titan

May 21, 2026

May 21, 2026

ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common shares - Stock Titan

May 21, 2026

May 21, 2026

ClearPoint Neuro (CLPT) director settles 12,417 RSUs into common stock - Stock Titan

May 21, 2026

May 21, 2026

Director Pascal Girin converts 12,417 RSUs into ClearPoint Neuro (CLPT) common shares - Stock Titan

May 21, 2026

May 21, 2026

ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common stock holdings - Stock Titan

May 21, 2026

May 21, 2026

16,000-share sale by CLPT (NASDAQ: CLPT) from vested restricted plan - Stock Titan

May 21, 2026

May 21, 2026

ClearPoint Neuro Earnings Call Signals Growth With Strain - TipRanks

May 21, 2026

May 21, 2026

Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN

May 21, 2026

May 18, 2026

ClearPoint Neuro Inc (CLPT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth By GuruFocus - Investing.com Canada

May 18, 2026

May 17, 2026

Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN

May 17, 2026

May 16, 2026

Avoiding Lag: Real-Time Signals in (CLPT) Movement - Stock Traders Daily

May 16, 2026

May 16, 2026

ClearPoint Neuro stock (US18507C1099): MAK Capital discloses 6.3% passive stake in CLPT - AD HOC NEWS

May 16, 2026

May 15, 2026

ClearPoint Neuro2026 Funding Rounds & List of Investors - Tracxn

May 15, 2026

May 15, 2026

MAK Capital reports 6.3% stake in ClearPoint Neuro (CLPT) via Schedule 13G/A - Stock Titan

May 15, 2026

May 15, 2026

ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint - ACCESS Newswire

May 15, 2026

May 14, 2026

Stifel reiterates Clearpoint Neuro stock Buy rating after Q1 beat - Investing.com UK

May 14, 2026

May 14, 2026

Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $16 - Moomoo

May 14, 2026

May 14, 2026

Stifel reiterates Clearpoint Neuro stock Buy rating after Q1 beat By Investing.com - Investing.com Nigeria

May 14, 2026